| An SI Board Since April 1998 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 8 |
0 |
0
|
SL |
|
A source close to the company states that Solar Pharmaceuticals, Ltd. may soon be announcing it's intention to acquire a private distributor of medical/laboratory equipment.
Solar's market capitalization is currently less than US$10m, should the transaction be completed, it would represent a major step towards becoming a high growth participant in the life science product market.
Management is very optimistic about Solar's prospects after the acquisition because it would provide the strategic platform to distribute Solar's high margin micro-liquid handling device which it currently manufactures in New York State.
Changes at the executive board level are also likely to take place in the near-term. Contingent upon the closing of the acquisition the company will be strengthening it's management team by appointing two senior managers who have longstanding careers in the life science business.
News releases and other company information can be found at their website: www.solarscientific.com
|
|
|
